Clinical Trials Browser

Phase 1 × Sleep Wake Disorders × Endocrine × Clear all

NCT01030939 2017-06-20

Study to Investigate Safety, Tolerability, Pharmacokinetics and Cardiac Function After Repeat Doses of SB-649868 in Healthy-volunteers

Phase 1 Completed

Sleep Wake Disorders, Multiple Endocrine Neoplasia Type 1